ClinConnect ClinConnect Logo
Search / Trial NCT04732676

Efficacy of a Smartphone App. Designed to Manage Craving & Individual Predictors of Substance Use/Addictive Behavior

Launched by CENTRE HOSPITALIER CHARLES PERRENS, BORDEAUX · Jan 26, 2021

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

Craving

ClinConnect Summary

This clinical trial is looking at a new smartphone app designed to help people manage cravings and understand their own behaviors related to addiction. The goal is to see if this app can effectively support individuals who are struggling with substance use or other addictive behaviors. The study is currently recruiting participants who are at least 18 years old and have a diagnosed addiction, whether to substances like drugs or alcohol, or behaviors like gambling. Participants must be seeking help for their addiction and have some time before starting formal treatment.

To take part in the study, individuals will need to be able to give their consent and be comfortable using a smartphone. Unfortunately, those who require immediate treatment for other medical or mental health issues, or who have difficulty with vision or hearing, won't be eligible. Participants will be able to use the app to help them manage their cravings and track their progress. This trial could be a great opportunity for those looking to gain additional support in their recovery journey.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants requesting help for substance or behavioral addiction in one of the participating specialized addiction treatment centers, and with more than 1-month-delay before treatment admission
  • Age \>= 18 years of age
  • With at least one substance or behavioral addiction (DSM-5 criteria)
  • Affiliated person or beneficiary of a social security scheme.
  • Free, informed and written consent signed by the participant and the investigator
  • Exclusion Criteria:
  • Medical, psychiatric or addiction condition that warrants immediate treatment intervention
  • Patients with somatic, cognitive or other disorders preventing the use of the device (deafness, impaired vision, illiteracy....)
  • Difficulty in understanding and / or writing French
  • Not familiar with the use of smartphone
  • Individuals participating in another study that includes an ongoing exclusion period
  • Be deprived of liberty due to an ongoing legal procedure
  • Individuals under legal protection
  • Be under guardianship or under curatorship

About Centre Hospitalier Charles Perrens, Bordeaux

Centre Hospitalier Charles Perrens, located in Bordeaux, is a leading psychiatric hospital dedicated to advancing mental health care through innovative clinical research. The institution focuses on developing and evaluating new therapeutic strategies for a range of psychiatric disorders, prioritizing patient safety and ethical standards. With a collaborative approach, the Centre engages multidisciplinary teams to conduct rigorous clinical trials aimed at enhancing treatment outcomes and improving quality of life for individuals facing mental health challenges. Through its commitment to research excellence, Centre Hospitalier Charles Perrens plays a pivotal role in contributing to the evolving landscape of psychiatric care.

Locations

Bordeaux, , France

Patients applied

0 patients applied

Trial Officials

MARC AURIACOMBE, MD, Prof

Principal Investigator

Centre Hospitalier CHARLES PERRENS

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials